Isatuximab survival benefit over VRd in transplant-ineligible newly diagnosed multiple myeloma
Dr Kao Vannarith speaks at the ecancer Choosing Wisely Cambodia 2023 congress on the 'Hemopathy burden at National Cancer Center’.
The congress was held in Phnom Penh, Cambodia on 18th March 2023.
This talk is in Khmer with the slides in English.
Isatuximab survival benefit over VRd in transplant-ineligible newly diagnosed multiple myeloma
Advancements in paediatric Acute lymphoblastic leukemia management
Multiple myeloma In Rwanda: The need for further research
Perspectives on advance care planning for advanced cancer in the Philippines
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
Lung cancer screening and treatment in the Philippines
Haemopathy burden in the National Cancer Center of Cambodia
Choosing wisely in multiple myeloma
IORT at the Asian Hospital and Medical Center